Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,267 total articles
Bluescape Energy Recapitalization & Restructuring Fund III LP, a 10% stakeholder in Riley Exploration Permian, Inc. (NASDAQ: REPX), sold 150,800 shares of common stock across three transactions from January 28 to January 30, 2026, generating approximately $4.2 million in proceeds. The sales were executed at varied prices. Separately, Riley Explorat…
Myriam Curet, Executive Vice President and Chief Medical Officer of Intuitive Surgical Inc (ISRG), sold 126 shares and exercised options for 126 shares under a pre-arranged trading plan. The transactions coincided with the company’s reported strong fourth-quarter 2025 results and multiple analyst upgrades tied to the da Vinci 5 rollout.
Morgan Stanley Co-President Daniel A. Simkowitz sold 32,968 shares of the firm's common stock on January 30, 2026, realizing roughly $6.02 million. The sale left him with 357,342.406 shares held directly and 1,794.818 shares held indirectly through a 401(k) plan. Separately, RBC Capital raised its price target on Morgan Stanley to $207 from $185 wh…
MapLight Therapeutics director Robert C. Malenka sold 34,604 shares of the company’s common stock across transactions from January 28 to January 30, 2026, generating roughly $635,857. The sales were carried out at prices between $18.11 and $19.05 per share and were reported as tax-related dispositions tied to the settlement of restricted stock unit…
Nurix Therapeutics Chief Financial Officer Hans van Houte completed two share sales totaling 3,661 shares on January 30, 2026, and on the same date acquired 11,496 shares through the exercise of restricted stock units. The transactions coincided with a flurry of analyst updates after the company's fourth-quarter 2025 earnings, during which several …
Nurix Therapeutics Chief Scientific Officer Gwenn Hansen completed two mandated share sales on January 30, 2026, disposing of 4,895 shares to meet tax-withholding obligations and realizing proceeds of roughly $81,249. The same day, Hansen exercised restricted stock units that converted into 11,816 shares at no cash cost, leaving her with 83,672 sha…
Eric Sprott, through a controlled Ontario holding company and its mining subsidiary, bought 200,000 Class A shares of Hycroft Mining Holding Corp. on January 29, 2026, paying $45.99 per share for a total of $9,198,000. The purchase raises his and affiliated entities' aggregate holding to 36,753,704 shares even as the stock trades below the purchase…
CoreWeave Chief Executive Michael N. Intrator sold $8.7 million of Class A Common Stock on January 28, 2026, under a pre-arranged 10b5-1 trading plan. The transactions, which included both personally held shares and shares held by Omnadora Capital LLC - where Intrator is the sole manager - occurred at prices between $103.611 and $113.8728 per share…
Masimo Corporation EVP Sampath Anand sold 12,180 shares on January 28, 2026, for roughly $2.56 million in multiple transactions priced between $136.56 and $138.09. Anand also exercised 30,000 stock options at $37.84 apiece, and now holds 40,909 shares directly. The sales were carried out under a Rule 10b5-1 plan. Separately, Masimo released prelimi…
CoreWeave Principal Accounting Officer Jeff Baker sold 5,143 shares of Class A common stock on January 29, 2026, generating about $533,759 at a weighted average price between $103.40 and $103.79. Baker also exercised options to acquire 12,500 shares tied to the vesting and settlement of restricted stock units. The company, trading at $93.19 at the …
Several entities identified as 10% owners, led by Endeavor Blockchain, LLC, reported purchases of Mawson Infrastructure Group Inc. (MIGI) shares on January 28, 2026. The group spent $192,502 at prices between $4.57 and $4.62. The transactions occurred while MIGI’s shares traded at $4.12, down 17.6% over the prior week and well below the insiders’ a…
Netflix Co-CEO Gregory K. Peters sold 105,781 shares of common stock on January 29, 2026 under a 10b5-1 plan, raising roughly $8.7 million. The transactions were disclosed in a Form 4 filed with the Securities and Exchange Commission. The company has recently received several analyst upgrades following stronger-than-expected Q4 FY2025 results and f…
Kratos Defense & Security Solutions director Jarvis Scot B sold 5,000 shares on January 28, 2026, under a previously established 10b5-1 plan. The transactions netted $591,380 and followed company announcements including a new 55,000-square-foot manufacturing and payload integration facility in Princess Anne, Maryland, and several contract and analy…
Agilon Health director John William Wulf purchased 81,000 shares of common stock on November 12, 2025, at a weighted average price of $0.6289 for a total of $50,940. The transaction increased his direct holdings to 365,857 shares, inclusive of restricted stock units. The purchase occurs as the company reports ongoing losses, a NYSE notice over low …
International Paper Chief Executive Andrew K. Silvernail purchased 50,000 shares on January 30, 2026, in a transaction valued at $1.99 million as the stock has fallen more than 6% over the past week and nearly 25% over the past year. The company reported a fourth-quarter 2025 EPS shortfall while revenue exceeded expectations. Analysts have reacted …
Nano Nuclear Energy Inc.'s CEO James John Walker sold 204,990 common shares on January 28, 2026, for roughly $6.6 million, with sale prices spanning $33.6438 to $35.2733. On the same day he exercised options to buy 170,000 shares at $1.50 each for $255,000. The company's shares have since fallen to $29.40, a 15.4% decline over the past week, and tr…
Angela L. Grant, Chief Legal Officer of Palomar Holdings, sold 1,447 shares on January 28, 2026, for $119.88 per share, netting $173,466. On the same date she received 3,827 shares from performance stock units vesting, and was granted 3,581 restricted stock units that will vest in three equal annual installments. Following the transactions, Grant d…
I Financial Ventures Group LLC, a roughly 10% holder of Nano Nuclear Energy Inc (NNE), sold common shares on January 28 and 29, 2026, for a total of $16.78 million across multiple tranches. The transactions, carried out under a Rule 10b5-1 plan adopted in September 2025, included sales at prices between $30.7623 and $35.25. Concurrently, the invest…
Palomar Holdings Chief Risk Officer Jonathan Knutzen reported a sale of 1,535 common shares at $119.88 on January 28, 2026, via a Form 4 filing. The transaction totaled $184,015. The filing also shows Knutzen acquired 4,779 performance stock units (PSUs) and 5,897 restricted stock units (RSUs) on the same day. After these moves he directly holds 24…
Palomar Holdings CFO T. Christopher Uchida sold 2,103 shares on January 28, 2026, for $119.88 per share, grossing $252,107. The sale followed the vesting of 5,660 performance stock units tied to financial targets. Palomar reported robust third-quarter 2025 results that exceeded forecasts, and an analyst raised the price target to $170 based on upda…
Palomar Holdings Inc. President Jon Christianson sold 1,991 shares at $119.88 on January 28, 2026, generating $238,681 in proceeds, according to a Form 4 filing. The filing also shows Christianson acquired 5,345 performance stock units valued at $0 and 7,912 restricted stock units, and now directly holds 62,985 shares. Separately, Palomar posted st…
Yu Jiang, President and Chairman of Nano Nuclear Energy Inc. (NNE), sold 507,621 shares of common stock on January 28 and 29, 2026 through I Financial Ventures Group LLC, generating roughly $16.8 million in proceeds. The sales occurred at prices between $30.7623 and $35.25. During the same two days Jiang exercised options to acquire a total of 500,…
Nano Nuclear Energy Inc.'s Chief Financial Officer, Jaisun Garcha, sold 74,990 shares on January 28, 2026, receiving roughly $2.55 million in proceeds from multiple trades executed between $33.6612 and $35.2314 per share. On the same day he exercised options to purchase 75,000 shares at $1.50 each for $112,500. After the transactions Garcha holds 2…
Bank First Corp director Todd A. Sprang bought 150 shares of the company's common stock on January 27, 2026, investing $21,159 at $141.06 per share. The transaction comes as the regional lender finalizes its acquisition of Centre 1 Bancorp, expanding branch footprint and total assets to roughly $6 billion, while analysts adjust valuations amid soli…
Amprius Technologies' Chief Technology Officer Stefan Constantin Ionel sold 39,690 shares of common stock on January 28, 2026, realizing roughly $476,351. The same day he exercised options to acquire 39,690 shares at strike prices between $0.05 and $0.62, for a total exercise cost of $2,035. After these moves, Ionel holds 748,696 shares directly, i…
